Our proprietary CellFX System leverages our patented Nano-Pulse Stimulation (NPS) technology, which is characterized by ultrafast electrical energy pulses with pulse durations from billionths up to a millionth of a second. When applied to targeted tissue, NPS energy pulses alter the function of the internal cellular organelles, without disrupting extracellular tissue, leading to regulated cell death (RCD).
read more >
Review the latest press releases, news, and events.
Now Hiring View all job positions >
Pulse Biosciences is a medical therapy company preparing to launch its first commercial offering, the CellFX System that harnesses our patented NPS technology, with initial applications in aesthetic dermatology. The company continues to conduct clinical studies on an ongoing basis to build a rich pipeline of potential medical applications.
read more >
CAUTION: Nano-Pulse Stimulation (NPS) technology and the CellFX System are for investigational use only.